{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["acute", "biotechnology", "chronic", "synthetic cannabinoids", "toxicity"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": [], "GeneralNote": [], "PMID": "28827985", "DateRevised": {"Year": "2020", "Month": "09", "Day": "30"}, "Article": {"ArticleDate": [{"Year": "2017", "Month": "05", "Day": "15"}], "Language": ["eng"], "ELocationID": ["10.17179/excli2017-257"], "Journal": {"ISSN": "1611-2156", "JournalIssue": {"Volume": "16", "PubDate": {"Year": "2017"}}, "Title": "EXCLI journal", "ISOAbbreviation": "EXCLI J"}, "ArticleTitle": "Endo-cannabinoids system and the toxicity of cannabinoids with a biotechnological approach.", "Pagination": {"StartPage": "688", "EndPage": "711", "MedlinePgn": "688-711"}, "Abstract": {"AbstractText": ["Cannabinoids have shown diverse and critical effects on the body systems, which alter the physiological functions. Synthetic cannabinoids are comparatively innovative misuse drugs with respect to their nature of synthesis. Synthetic cannabinoids therapy in healthy, chain smokers, and alcoholic individuals cause damage to the immune and nervous system, eventually leading to intoxication throughout the body. Relevant studies were retrieved using major electronic databases such as PubMed, EMBASE, Medline, Scopus, and Google Scholar. The extensive use of <i>Cannabis Sativa</i> L. (<i>C. Sativa</i>) and its derivatives/analogues such as the nonpsychoactive dimethyl heptyl homolog (CBG-DMH), and tetrahydrocannabivarin (THCV) amongst juveniles and adults have been enhanced in recent years. Cannabinoids play a crucial role in the induction of respiratory, reproductive, immune and carcinogenic effects; however, potential data about mutagenic and developmental effects are still insufficient. The possible toxicity associated with the prolong use of cannabinoids acts as a tumor promoter in animal models and humans. Particular synthetic cannabinoids and analogues have low affinity for CB1 or CB2 receptors, while some synthetic members like \u03949-THC have high affinity towards these receptors. Cannabinoids and their derivatives have a direct or indirect association with acute and long-term toxicity. To reduce/attenuate cannabinoids toxicity, pharmaceutical biotechnology and cloning methods have opened a new window to develop cannabinoids encoding the gene tetrahydrocannabinolic acid (THCA) synthase. Plant revolution and regeneration hindered genetic engineering in <i>C. Sativa.</i> The genetic culture suspension of <i>C. Sativa</i> can be transmuted by the use of <i>Agrobacterium tumefaciens</i> to overcome its toxicity. The main aim of the present review was to collect evidence of the endo-cannabinoid system (ECS), cannabinoids toxicity, and the potential biotechnological approach of cannabinoids synthesis."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "International Campus, Tehran University of Medical Sciences (IC-TUMS), Tehran, Iran."}, {"Identifier": [], "Affiliation": "Toxicology and Diseases Group, Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran, Iran."}, {"Identifier": [], "Affiliation": "Department of Toxicology and Pharmacology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran."}], "LastName": "Niaz", "ForeName": "Kamal", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "International Campus, Tehran University of Medical Sciences (IC-TUMS), Tehran, Iran."}, {"Identifier": [], "Affiliation": "Toxicology and Diseases Group, Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran, Iran."}, {"Identifier": [], "Affiliation": "Department of Toxicology and Pharmacology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran."}], "LastName": "Khan", "ForeName": "Fazlullah", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "International Campus, Tehran University of Medical Sciences (IC-TUMS), Tehran, Iran."}, {"Identifier": [], "Affiliation": "Toxicology and Diseases Group, Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran, Iran."}], "LastName": "Maqbool", "ForeName": "Faheem", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Toxicology and Diseases Group, Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran, Iran."}, {"Identifier": [], "Affiliation": "Department of Toxicology and Pharmacology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran."}, {"Identifier": [], "Affiliation": "Medicinal Plants Research Center, Institute of Medicinal Plants, ACECR, Karaj, Iran."}], "LastName": "Momtaz", "ForeName": "Saeideh", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "International Campus, Tehran University of Medical Sciences (IC-TUMS), Tehran, Iran."}, {"Identifier": [], "Affiliation": "Toxicology and Diseases Group, Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran, Iran."}, {"Identifier": [], "Affiliation": "Department of Toxicology and Pharmacology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran."}], "LastName": "Ismail Hassan", "ForeName": "Fatima", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Toxicology and Diseases Group, Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran, Iran."}, {"Identifier": [], "Affiliation": "Faculty of Pharmacy, Eastern Mediterranean University, Famagusta, North Cyprus Mersin 10, Turkey."}], "LastName": "Nobakht-Haghighi", "ForeName": "Navid", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Toxicology and Diseases Group, Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran, Iran."}], "LastName": "Rahimifard", "ForeName": "Mahban", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "International Campus, Tehran University of Medical Sciences (IC-TUMS), Tehran, Iran."}, {"Identifier": [], "Affiliation": "Toxicology and Diseases Group, Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran, Iran."}, {"Identifier": [], "Affiliation": "Department of Toxicology and Pharmacology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran."}], "LastName": "Abdollahi", "ForeName": "Mohammad", "Initials": "M"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Germany", "MedlineTA": "EXCLI J", "NlmUniqueID": "101299402", "ISSNLinking": "1611-2156"}}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Ahluwalia J, Urban L, Bevan S, Nagy I. Anandamide regulates neuropeptide release from capsaicin\u2010sensitive primary sensory neurons by activating both the cannabinoid 1 receptor and the vanilloid receptor 1 in vitro. Eur J Neurosci. 2003;17:2611\u20132618.", "ArticleIdList": ["12823468"]}, {"Citation": "Akinshola B, Chakrabarti A, Onaivi E. In-vitro and in-vivo action of cannabinoids. Neurochem Res. 1999;24:1233\u20131240.", "ArticleIdList": ["10492518"]}, {"Citation": "Akinshola BE, Taylor RE, Ogunseitan AB, Onaivi ES. Anandamide inhibition of recombinant AMPA receptor subunits in Xenopus oocytes is increased by forskolin and 8-bromo-cyclic AMP. Naunyn-Schmiedeberg's Arch Pharmacol. 1999;360:242\u2013248.", "ArticleIdList": ["10543424"]}, {"Citation": "Amar MB. Cannabinoids in medicine: A review of their therapeutic potential. J Ethnopharmacol. 2006;105:1\u201325.", "ArticleIdList": ["16540272"]}, {"Citation": "Anggadiredja K, Nakamichi M, Hiranita T, Tanaka H, Shoyama Y, Watanabe S, et al. Endocannabinoid system modulates relapse to methamphetamine seeking: possible mediation by the arachidonic acid cascade. Neuropsychopharmacology. 2004;29:1470\u20131478.", "ArticleIdList": ["15085091"]}, {"Citation": "Anggadiredja K, Yamaguchi T, Tanaka H, Shoyama Y, Watanabe S, Yamamoto T. Prostaglandin E 2 attenuates SR141716A-precipitated withdrawal in tetrahydrocannabinol-dependent mice. Brain Res. 2003;966:47\u201353.", "ArticleIdList": ["12646307"]}, {"Citation": "Arnold RM. Cannabinoids may improve symptoms for some indications but increase adverse events. Ann Intern Med. 2015;163:JC4.", "ArticleIdList": ["26370031"]}, {"Citation": "Arnone M, Maruani J, Chaperon F, Thi\u00e9bot MH, Poncelet M, Soubri\u00e9 P, et al. Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors. Psychopharmacology. 1997;132:104\u2013106.", "ArticleIdList": ["9272766"]}, {"Citation": "Ashton CH. Pharmacology and effects of cannabis: a brief review. Br J Psychiatry. 2001;178:101\u2013106.", "ArticleIdList": ["11157422"]}, {"Citation": "Baker D, Pryce G, Giovannoni G, Thompson AJ. The therapeutic potential of cannabis. Lancet Neurol. 2003;2:291\u2013298.", "ArticleIdList": ["12849183"]}, {"Citation": "Barann M, Molderings G, Br\u00fcss M, B\u00f6nisch H, Urban B, G\u00f6thert M. Direct inhibition by cannabinoids of human 5\u2010HT3A receptors: Probable involvement of an allosteric modulatory site. Br J Pharmacol. 2002;137:589\u2013596.", "ArticleIdList": ["PMC1573528", "12381672"]}, {"Citation": "Barratt MJ, Cakic V, Lenton S. Patterns of synthetic cannabinoid use in Australia. Drug Alcohol Rev. 2013;32:141\u2013146.", "ArticleIdList": ["23043552"]}, {"Citation": "Bayewitch M, Rhee M-H, Avidor-Reiss T, Breuer A, Mechoulam R, Vogel Z. (-)-\u03949 Tetrahydrocannabinol antagonizes the peripheral cannabinoid receptor-mediated inhibition of adenylyl cyclase. J Biol Chem. 1996;271:9902\u20139905.", "ArticleIdList": ["8626625"]}, {"Citation": "Begg M, Pacher P, B\u00e1tkai S, Osei-Hyiaman D, Offert\u00e1ler L, Mo FM, et al. Evidence for novel cannabinoid receptors. Pharmacol Ther. 2005;106:133\u2013145.", "ArticleIdList": ["15866316"]}, {"Citation": "Behonick G, Shanks KG, Firchau DJ, Mathur G, Lynch CF, Nashelsky M, et al. Four postmortem case reports with quantitative detection of the synthetic cannabinoid, 5F-PB-22. J Anal Toxicol. 2014;38:559\u2013562.", "ArticleIdList": ["PMC4334789", "24876364"]}, {"Citation": "Berdyshev E. Cannabinoid receptors and the regulation of immune response. Chem Phys Lipids. 2000;108:169\u2013190.", "ArticleIdList": ["11106790"]}, {"Citation": "Berry EM, Mechoulam R. Tetrahydrocannabinol and endocannabinoids in feeding and appetite. Pharmacol Ther. 2002;95:185\u2013190.", "ArticleIdList": ["12182965"]}, {"Citation": "Bersani G, Orlandi V, Kotzalidis G, Pancheri P. Cannabis and schizophrenia: impact on onset, course, psychopathology and outcomes. Eur Arch Psychiatry Clin Neurosci. 2002;252:86\u201392.", "ArticleIdList": ["12111342"]}, {"Citation": "Bisogno T, Maurelli S, Melck D, De Petrocellis L, Di Marzo V. Biosynthesis, uptake, and degradation of anandamide and palmitoylethanolamide in leukocytes. J Biol Chem. 1997;272:3315\u20133323.", "ArticleIdList": ["9013571"]}, {"Citation": "Bouaboula M, Rinaldi M, Carayon P, Carillon C, Delpech B, Shire D, et al. Cannabinoid\u2010receptor expression in human leukocytes. Eur J Biochem. 1993;214:173\u2013180.", "ArticleIdList": ["8508790"]}, {"Citation": "Budney AJ, Hughes JR. The cannabis withdrawal syndrome. Curr Opin Psychiatry. 2006;19:233\u2013238.", "ArticleIdList": ["16612207"]}, {"Citation": "Cabral G, Mishkin E. Delta\u20109\u2010tetrahydrocannabinol inhibits macrophage protein expression in response to bacterial immunomodulators. J Toxicol Environ Health A. 1989;26:175\u2013182.", "ArticleIdList": ["2537903"]}, {"Citation": "Cabral GA, Ferreira GA, Jamerson MJ. Endocannabinoids and the immune system in health and disease endocannabinoids. Handb Exper Pharmacol. 2015;231:185\u2013211.", "ArticleIdList": ["26408161"]}, {"Citation": "Cabral GA, Pettit DAD. Drugs and immunity: cannabinoids and their role in decreased resistance to infectious disease. J Neuroimmunol. 1998;83:116\u2013123.", "ArticleIdList": ["9610679"]}, {"Citation": "Cabral GA, Staab A. Effects on the immune system cannabinoids. Berlin: Springer; 2005. pp. 385\u2013423.", "ArticleIdList": ["16596782"]}, {"Citation": "Campbell A. The Australian illicit drug guide: every person's guide to illicit drugs-their use, effects and history, treatment options and legal penalties. Melbourne: Black Inc; 2001."}, {"Citation": "Carlisle S, Marciano-Cabral F, Staab A, Ludwick C, Cabral G. Differential expression of the CB 2 cannabinoid receptor by rodent macrophages and macrophage-like cells in relation to cell activation. Int Immunopharmacol. 2002;2:69\u201382.", "ArticleIdList": ["11789671"]}, {"Citation": "Cheer J, Cadogan AK, Marsden C, Fone K, Kendall D. Modification of 5-HT 2 receptor mediated behaviour in the rat by oleamide and the role of cannabinoid receptors. Neuropharmacology. 1999;38:533\u2013541.", "ArticleIdList": ["10221757"]}, {"Citation": "Choi YH, Kim HK, Hazekamp A, Erkelens C, Lefeber AW, Verpoorte R. Metabolomic differentiation of cannabis sativa cultivars using 1H NMR spectroscopy and principal component analysis. J Nat Prod. 2004;67:953\u2013957.", "ArticleIdList": ["15217272"]}, {"Citation": "Christopoulos A, Wilson K. Interaction of anandamide with the M 1 and M 4 muscarinic acetylcholine receptors. Brain Res. 2001;915:70\u201378.", "ArticleIdList": ["11578621"]}, {"Citation": "Cohen J, Morrison S, Greenberg J, Saidinejad M. Clinical presentation of intoxication due to synthetic cannabinoids. Pediatrics. 2012;129:e1064\u2013e1067.", "ArticleIdList": ["22430444"]}, {"Citation": "Colombo G, Agabio R, Diaz G, Lobina C, Reali R, Gessa GL. Appetite suppression and weight loss after the cannabinoid antagonist SR 141716. Life Sci. 1998;63:PL113\u2013PL117.", "ArticleIdList": ["9718088"]}, {"Citation": "Consroe P, Laguna J, Allender J, Snider S, Stern L, Sandyk R, et al. Controlled clinical trial of cannabidiol in Huntington's disease. Pharmacol Biochem Behav. 1991;40:701\u2013708.", "ArticleIdList": ["1839644"]}, {"Citation": "Costa B, Vailati S, Colleoni M. SR 141716A, a cannabinoid receptor antagonist, reverses the behavioural effects of anandamide-treated rats. Behav Pharmacol. 1999;10:327\u2013331.", "ArticleIdList": ["10780247"]}, {"Citation": "Croxford JL, Yamamura T. Cannabinoids and the immune system: potential for the treatment of inflammatory diseases? J Neuroimmunol. 2005;166:3\u201318.", "ArticleIdList": ["16023222"]}, {"Citation": "D\u2019Souza DC, Sewell RA, Ranganathan M. Cannabis and psychosis/schizophrenia: human studies. Eur Arch Psychiatry Clin Neurosci. 2009;259:413\u2013431.", "ArticleIdList": ["PMC2864503", "19609589"]}, {"Citation": "De Filippis D, D\u2019amico A, Iuvone T. Cannabinomimetic control of mast cell mediator release: new perspective in chronic inflammation. J Neuroendocrinol. 2008;20(s1):20\u201325.", "ArticleIdList": ["18426495"]}, {"Citation": "De Oliveira GL, Voloch MH, Sztulman GB, Neto ON, Yonamine M. Cannabinoid contents in cannabis products seized in S\u00e3o Paulo, Brazil, 2006\u20132007. Forensic Toxicol. 2008;26:31\u201335."}, {"Citation": "De Petrocellis L, Di Marzo V. Role of endocannabinoids and endovanilloids in Ca 2+ signalling. Cell Calcium. 2009;45:611\u2013624.", "ArticleIdList": ["19356798"]}, {"Citation": "Derocq JM, Segui M, Marchand J, Le Fur G, Casellas P. Cannabinoids enhance human B\u2010cell growth at low nanomolar concentrations. FEBS Lett. 1995;369:177\u2013182.", "ArticleIdList": ["7544292"]}, {"Citation": "Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, et al. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science. 1992;258(5090):1946\u20131949.", "ArticleIdList": ["1470919"]}, {"Citation": "Dewey WL. Cannabinoid pharmacology. Pharmacol Rev. 1986;38:151\u2013178.", "ArticleIdList": ["3529128"]}, {"Citation": "Di Marzo V. \u2018Endocannabinoids\u2019 and other fatty acid derivatives with cannabimimetic properties: biochemistry and possible physiopathological relevance. Biochim Biophys Acta. 1998;1392:153\u2013175.", "ArticleIdList": ["9630590"]}, {"Citation": "Di Marzo V. CB 1 receptor antagonism: biological basis for metabolic effects. Drug Dis Today. 2008;13:1026\u20131041.", "ArticleIdList": ["18824122"]}, {"Citation": "Di Marzo V, Petrosino S. Endocannabinoids and the regulation of their levels in health and disease. Curr Opin Lipidol. 2007;18:129\u2013140.", "ArticleIdList": ["17353660"]}, {"Citation": "Dinh TP, Freund TF, Piomelli D. A role for monoglyceride lipase in 2-arachidonoylglycerol inactivation. Chem Phys Lipids. 2002;121:149\u2013158.", "ArticleIdList": ["12505697"]}, {"Citation": "Domino EE. Cannabinoids and the cholinergic system. In: Nahas GG, Sutin KM, Harvey DJ, Agurell S, et al., editors. Marihuana and medicine. New York: Humana Press; 1999. pp. 223\u2013226."}, {"Citation": "Egashira N, Matsumoto Y, Mishima K, Iwasaki K, Fujioka M, Matsushita M, et al. Low dose citalopram reverses memory impairment and electroconvulsive shock-induced immobilization. Pharmacol Biochem Behav. 2006;83:161\u2013167.", "ArticleIdList": ["16492387"]}, {"Citation": "Eisenstein TK, Meissler JJ. Effects of cannabinoids on t-cell function and resistance to infection. J Neuroimmune Pharmacol. 2015;10:204\u2013216.", "ArticleIdList": ["PMC4470840", "25876735"]}, {"Citation": "El-Alfy AT, Ivey K, Robinson K, Ahmed S, Radwan M, Slade D, et al. Antidepressant-like effect of \u0394 9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L. Pharmacol Biochem Behav. 2010;95:434\u2013442.", "ArticleIdList": ["PMC2866040", "20332000"]}, {"Citation": "Fan P. Cannabinoid agonists inhibit the activation of 5-HT3 receptors in rat nodose ganglion neurons. J Neurophysiol. 1995;73:907\u2013910.", "ArticleIdList": ["7760148"]}, {"Citation": "Feeney M, Punja Z. Tissue culture and Agrobacterium-mediated transformation of hemp (Cannabis sativa L.) In Vitro Cell Dev Biol Plant. 2003;39:578\u2013585."}, {"Citation": "Fine PG, Rosenfeld MJ. The endocannabinoid system, cannabinoids, and pain. Rambam Maimonides Med J. 2013;4(4):e0022.", "ArticleIdList": ["PMC3820295", "24228165"]}, {"Citation": "Fischer-Stenger K, Updegrove AW, Cabral G. \u03949-Tetrahydrocannabinol decreases cytotoxic T lymphocyte activity to herpes simplex virus Type 1-infected cells. Exp Biol Med. 1992;200:422\u2013430.", "ArticleIdList": ["1319584"]}, {"Citation": "Fride E, Barg J, Levy R, Saya D, Heldman E, Mechoulam R, et al. Low doses of anandamides inhibit pharmacological effects of delta 9-tetrahydrocannabinol. J Pharm Exp Ther. 1995;272:699\u2013707.", "ArticleIdList": ["7853184"]}, {"Citation": "Giuffrida A, Beltramo M, Piomelli D. Mechanisms of endocannabinoid inactivation: biochemistry and pharmacology. J Pharmacol Exper Ther. 2001;298:7\u201314.", "ArticleIdList": ["11408519"]}, {"Citation": "Godlewski G, G\u00f6thert M, Malinowska B. Cannabinoid receptor\u2010independent inhibition by cannabinoid agonists of the peripheral 5\u2010HT3 receptor\u2010mediated von Bezold\u2013Jarisch reflex. Br J Pharmacol. 2003;138:767\u2013774.", "ArticleIdList": ["PMC1573725", "12642377"]}, {"Citation": "Gokoh M, Kishimoto S, Oka S, Metani Y, Sugiura T. 2-Arachidonoylglycerol, an endogenous cannabinoid receptor ligand, enhances the adhesion of HL-60 cells differentiated into macrophage-like cells and human peripheral blood monocytes. FEBS Lett. 2005;579:6473\u20136478.", "ArticleIdList": ["16288744"]}, {"Citation": "Gorelick DA, Goodwin RS, Schwilke E, Schwope DM, Darwin WD, Kelly DL, et al. Tolerance to effects of high-dose oral \u03b49-tetrahydrocannabinol and plasma cannabinoid concentrations in male daily cannabis smokers. J Anal Toxicol. 2012;37:11\u201316.", "ArticleIdList": ["PMC3584989", "23074216"]}, {"Citation": "Goto Y, Shima Y, Morimoto S, Shoyama Y, Murakami H, Kusai A, et al. Determination of tetrahydrocannabinolic acid-carrier protein conjugate by matrix\u2010assisted laser desorption/ionization mass spectrometry and antibody formation. Org Mass Spectrom. 1994;29:668\u2013671."}, {"Citation": "Grotenhermen F. Cannabinoids and the endocannabinoid system. Cannabinoids. 2006;1(1):10\u201314."}, {"Citation": "Grotenhermen F. Pharmacology of cannabinoids. Neuroendocrinol Lett. 2004;25:14\u201323.", "ArticleIdList": ["15159677"]}, {"Citation": "Grotenhermen F, M\u00fcller-Vahl K. The therapeutic potential of cannabis and cannabinoids. Dtsch Arztebl Int. 2012;109:495\u2013501.", "ArticleIdList": ["PMC3442177", "23008748"]}, {"Citation": "Grotenhermen F, Russo EB. Cannabis and cannabinoids: pharmacology, toxicology, and therapeutic potential. Abingdon, Oxon: Routledge; 2002."}, {"Citation": "Grundy RI. The therapeutic potential of the cannabinoids in neuroprotection. Expert Opin Investig Drugs. 2002;11:1365\u20131374.", "ArticleIdList": ["12387700"]}, {"Citation": "Gunderson EW, Haughey HM, Ait\u2010Daoud N, Joshi AS, Hart CL. \u201cSpice\u201d and \u201cK2\u201d herbal highs: a case series and systematic review of the clinical effects and biopsychosocial implications of synthetic cannabinoid use in humans. Am J Addict. 2012;21:320\u2013326.", "ArticleIdList": ["22691010"]}, {"Citation": "Gurney SM, Scott K, Kacinko S, Presley B, Logan B. Pharmacology, toxicology, and adverse effects of synthetic cannabinoid drugs. Forensic Sci Rev. 2014;26:54\u201378.", "ArticleIdList": ["26226970"]}, {"Citation": "Hall W. What has research over the past two decades revealed about the adverse health effects of recreational cannabis use? Addiction. 2015;110:19\u201335.", "ArticleIdList": ["25287883"]}, {"Citation": "Hartman RL, Brown TL, Milavetz G, Spurgin A, Pierce RS, Gorelick DA, et al. Cannabis effects on driving lateral control with and without alcohol. Drug Alcohol Depend. 2015;154:25\u201337.", "ArticleIdList": ["PMC4536116", "26144593"]}, {"Citation": "Hartman RL, Huestis MA. Cannabis effects on driving skills. Clin Chem. 2013;59:478\u2013492.", "ArticleIdList": ["PMC3836260", "23220273"]}, {"Citation": "Hasani-Ranjbar S, Nayebi N, Larijani B, Abdollahi M. A systematic review of the efficacy and safety of herbal medicines used in the treatment of obesity. World J Gastroenterol. 2009;15:3073.", "ArticleIdList": ["PMC2705729", "19575486"]}, {"Citation": "Hegde VL, Hegde S, Cravatt BF, Hofseth LJ, Nagarkatti M, Nagarkatti PS. Attenuation of experimental autoimmune hepatitis by exogenous and endogenous cannabinoids: involvement of regulatory T cells. Mol Pharmacol. 2008;74:20\u201333.", "ArticleIdList": ["PMC2828293", "18388242"]}, {"Citation": "Hollister LE. Health aspects of cannabis. Pharmacol Rev. 1986;38:1\u201320.", "ArticleIdList": ["3520605"]}, {"Citation": "Howlett A. Cannabinoid receptor signaling. Cannabinoids. Handb Exper Pharmacol. 2005;168:53\u201379.", "ArticleIdList": ["16596771"]}, {"Citation": "Howlett A, Barth F, Bonner T, Cabral G, Casellas P, Devane WA, et al. International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev. 2002;54:161\u2013202.", "ArticleIdList": ["12037135"]}, {"Citation": "Hoyte CO, Jacob J, Monte AA, Al-Jumaan M, Bronstein AC, Heard KJ. A characterization of synthetic cannabinoid exposures reported to the National Poison Data System in 2010. Ann Emerg Med. 2012;60:435\u2013438.", "ArticleIdList": ["22575211"]}, {"Citation": "Hwang SW, Cho H, Kwak J, Lee SY, Kang CJ, Jung J, et al. Direct activation of capsaicin receptors by products of lipoxygenases: endogenous capsaicin-like substances. Proc Natl Acad Sci USA. 2000;97:6155\u20136160.", "ArticleIdList": ["PMC18574", "10823958"]}, {"Citation": "Iversen L. Cannabis and the brain. Brain. 2003;126:1252\u20131270.", "ArticleIdList": ["12764049"]}, {"Citation": "Johns A. Psychiatric effects of cannabis. Br J Psychiatry. 2001;178:116\u2013122.", "ArticleIdList": ["11157424"]}, {"Citation": "Kaplan BL. The role of CB 1 in immune modulation by cannabinoids. Pharmacol Ther. 2013;137:365\u2013374.", "ArticleIdList": ["23261520"]}, {"Citation": "Klein TW. Cannabinoid-based drugs as anti-inflammatory therapeutics. Nat Rev Immunol. 2005;5:400\u2013411.", "ArticleIdList": ["15864274"]}, {"Citation": "Klein TW, Newton C, Larsen K, Lu L, Perkins I, Nong L, et al. The cannabinoid system and immune modulation. J Leukoc Biol. 2003;74:486\u2013496.", "ArticleIdList": ["12960289"]}, {"Citation": "Klein TW, Newton C, Zhu W, Daaka Y, Friedman H. \u03949-tetrahydrocannabinol, cytokines, and immunity to Legionella pneumophila. Exp Biol Med. 1995;209:205\u2013212.", "ArticleIdList": ["7777582"]}, {"Citation": "Klein TW, Newton CA, Nakachi N, Friedman H. \u03949-tetrahydrocannabinol treatment suppresses immunity and early IFN-\u03b3, IL-12, and IL-12 receptor \u03b22 responses to Legionella pneumophila infection. J Immunol. 2000;164:6461\u20136466.", "ArticleIdList": ["10843702"]}, {"Citation": "Kojoma M, Seki H, Yoshida S, Muranaka T. DNA polymorphisms in the tetrahydrocannabinolic acid (THCA) synthase gene in \u201cdrug-type\u201d and \u201cfiber-type\u201d Cannabis sativa L. Forensic Sci Int. 2006;159:132\u2013140.", "ArticleIdList": ["16143478"]}, {"Citation": "Kronstrand R, Roman M, Andersson M, Eklund A. Toxicological findings of synthetic cannabinoids in recreational users. J Anal Toxicol. 2013;37:534\u2013541.", "ArticleIdList": ["23970540"]}, {"Citation": "Kumar R, Chambers W, Pertwee R. Pharmacological actions and therapeutic uses of cannabis and cannabinoids. Anaesthesia. 2001;56:1059\u20131068.", "ArticleIdList": ["11703238"]}, {"Citation": "Labay LM, Caruso JL, Gilson TP, Phipps RJ, Knight LD, Lemos NP, et al. Synthetic cannabinoid drug use as a cause or contributory cause of death. Forensic Sci Int. 2016;260:31\u201339.", "ArticleIdList": ["26795398"]}, {"Citation": "Lambert DM, Fowler CJ. The endocannabinoid system: drug targets, lead compounds, and potential therapeutic applications. J Med Chem. 2005;48:5059\u20135087.", "ArticleIdList": ["16078824"]}, {"Citation": "Lazzerini PE, Natale M, Gianchecchi E, Capecchi PL, Montilli C, Zimbone S, et al. Adenosine A2A receptor activation stimulates collagen production in sclerodermic dermal fibroblasts either directly and through a cross-talk with the cannabinoid system. J Mol Med. 2012;90:331\u2013342.", "ArticleIdList": ["22033526"]}, {"Citation": "Lee CY, Wey SP, Liao MH, Hsu WL, Wu HY, Jan TR. A comparative study on cannabidiol-induced apoptosis in murine thymocytes and EL-4 thymoma cells. Int Immunopharmacol. 2008;8:732\u2013740.", "ArticleIdList": ["18387516"]}, {"Citation": "Lee SF, Newton C, Widen R, Friedman H, Klein TW. Differential expression of cannabinoid CB 2 receptor mRNA in mouse immune cell subpopulations and following B cell stimulation. Eur J Pharmacol. 2001;423:235\u2013241.", "ArticleIdList": ["11448490"]}, {"Citation": "Lemos NP. Driving under the influence of synthetic cannabinoid receptor agonist XLR\u201011. J Forensic Sci. 2014;59:1679\u20131683.", "ArticleIdList": ["25088081"]}, {"Citation": "Lichtman A, Martin B. Cannabinoid tolerance and dependence. Cannabinoids. Handb Exper Pharmacol. 2005;168:691\u2013717.", "ArticleIdList": ["16596793"]}, {"Citation": "Lopez-Cepero M, Friedman M, Klein T, Friedman H. Tetrahydrocannabinol-induced suppression of macrophage spreading and phagocytic activity in vitro. J Leukoc Biol. 1986;39:679\u2013686.", "ArticleIdList": ["3011935"]}, {"Citation": "Lu T, Newton C, Perkins I, Friedman H, Klein TW. Cannabinoid treatment suppresses the T-helper cell-polarizing function of mouse dendritic cells stimulated with Legionella pneumophila infection. J Pharmacol Exp Ther. 2006;319:269\u2013276.", "ArticleIdList": ["16837556"]}, {"Citation": "Mackie K. Cannabinoid receptors: where they are and what they do. J Neuroendocrinol. 2008;20(s1):10\u201314.", "ArticleIdList": ["18426493"]}, {"Citation": "Maor Y, Horowitz M, Gallily R, Mechoulam R. Cannabigerol-dimethyl heptyl (CBG-DMH), a synthetic cannabinoid with hypotensive and vasorelaxant properties. XVth Symposium on the Cannabinoids, June 24th - June 27th, 2005, Clearwater, FL; Clearwater, FL: ICRS, International Cannabinoid Research Society; 2005."}, {"Citation": "Maresz K, Carrier EJ, Ponomarev ED, Hillard CJ, Dittel BN. Modulation of the cannabinoid CB2 receptor in microglial cells in response to inflammatory stimuli. J Neurochem. 2005;95:437\u2013445.", "ArticleIdList": ["16086683"]}, {"Citation": "Marsicano G, Moosmann B, Hermann H, Lutz B, Behl C. Neuroprotective properties of cannabinoids against oxidative stress: role of the cannabinoid receptor CB1. J Neurochem. 2002;80:448\u2013456.", "ArticleIdList": ["11905991"]}, {"Citation": "Mattes RD, Shaw LM, Engelman K. Effects of cannabinoids (marijuana) on taste intensity and hedonic ratings and salivary flow of adults. Chem Senses. 1994;19:125\u2013140.", "ArticleIdList": ["8055263"]}, {"Citation": "McKallip RJ, Lombard C, Martin BR, Nagarkatti M, Nagarkatti PS. \u03949-Tetrahydrocannabinol-induced apoptosis in the thymus and spleen as a mechanism of immunosuppression in vitro and in vivo. J Pharmacol Exp Ther. 2002;302:451\u2013465.", "ArticleIdList": ["12130702"]}, {"Citation": "Mechoulam R. Plant cannabinoids: a neglected pharmacological treasure trove. Br J Pharmacol. 2005;146:913\u2013915.", "ArticleIdList": ["PMC1751232", "16205721"]}, {"Citation": "Mechoulam R, Ben-Zvi Z. Carboxylation of resorcinols with methylmagnesium carbonate. Synthesis of cannabinoid acids. J Chem Society D: Chem Commun. 1969;(7):343\u2013344."}, {"Citation": "Munro S, Thomas KL, Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature. 1993;365:61\u201365.", "ArticleIdList": ["7689702"]}, {"Citation": "Munson AE. Marijuana and immunity. In: Tinklenberg JR, editor. Marijuana and health hazards: methodological issues in current research. New York: Academic Press; 1975. pp. 39\u201345."}, {"Citation": "Musshoff F, Madea B, Kernbach-Wighton G, Bicker W, Kneisel S, Hutter M, et al. Driving under the influence of synthetic cannabinoids (\u201cSpice\u201d): a case series. Int J Legal Med. 2014;128:59\u201364.", "ArticleIdList": ["23636569"]}, {"Citation": "Newton CA. Cannabinoids and the immune system. Pain. 2001;6:95\u2013101.", "ArticleIdList": ["11854771"]}, {"Citation": "Newton CA, Klein TW, Friedman H. Secondary immunity to Legionella pneumophila and Th1 activity are suppressed by delta-9-tetrahydrocannabinol injection. Infect Immun. 1994;6:4015\u20134020.", "ArticleIdList": ["PMC303061", "8063421"]}, {"Citation": "N\u00fa\u00f1ez E, Benito C, Pazos MR, Barbachano A, Fajardo O, Gonz\u00e1lez S, et al. Cannabinoid CB2 receptors are expressed by perivascular microglial cells in the human brain: an immunohistochemical study. Synapse. 2004;53:208\u2013213.", "ArticleIdList": ["15266552"]}, {"Citation": "Nunez L, Gurpegui M. Cannabis\u2010induced psychosis: a cross\u2010sectional comparison with acute schizophrenia. Acta Psychiat Scand. 2002;105:173\u2013178.", "ArticleIdList": ["11939970"]}, {"Citation": "O'Sullivan SE, Kendall DA, Randall MD. Characterisation of the vasorelaxant properties of the novel endocannabinoid N\u2010arachidonoyl\u2010dopamine (NADA) Br J Pharmacol. 2004;141:803\u2013812.", "ArticleIdList": ["PMC1574254", "14769783"]}, {"Citation": "Oz M, Zhang L, Morales M. Endogenous cannabinoid, anandamide, acts as a noncompetitive inhibitor on 5\u2010HT3 receptor\u2010mediated responses in Xenopus oocytes. Synapse. 2002;46:150\u2013156.", "ArticleIdList": ["12325042"]}, {"Citation": "Pacher P, B\u00e1tkai S, Kunos G. The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev. 2006;58:389\u2013462.", "ArticleIdList": ["PMC2241751", "16968947"]}, {"Citation": "Pacher P, Mechoulam R. Is lipid signaling through cannabinoid 2 receptors part of a protective system? Prog Lipid Res. 2011;50:193\u2013211.", "ArticleIdList": ["PMC3062638", "21295074"]}, {"Citation": "Pacifico D, Miselli F, Micheler M, Carboni A, Ranalli P, Mandolino G. Genetics and marker-assisted selection of the chemotype in Cannabis sativa L. Mol Breed. 2006;17:257\u2013268."}, {"Citation": "Pagotto U, Marsicano G, Cota D, Lutz B, Pasquali R. The emerging role of the endocannabinoid system in endocrine regulation and energy balance. Endocr Rev. 2006;27:73\u2013100.", "ArticleIdList": ["16306385"]}, {"Citation": "Park B, McPartland JM, Glass M. Cannabis, cannabinoids and reproduction. Prostaglandins, Leukot Essent Fatty Acids. 2004;70:189\u2013197.", "ArticleIdList": ["14683692"]}, {"Citation": "Parry CD, Myers BJ. Legalising medical use of cannabis in South Africa: Is the empirical evidence sufficient to support policy shifts in this direction? S Afr Med J. 2014;104:399\u2013400.", "ArticleIdList": ["25214244"]}, {"Citation": "Pertwee R. In vivo interactions between psychotropic cannabinoids and other drugs involving central and peripheral neurochemical mediators. In: Murphy L, Bartke A, editors. Marijuana/Cannabinoids: neurobiology and neurophysiology. Boca Raton, FL: CRC Press; 1992. pp. 165\u2013218."}, {"Citation": "Pertwee R. Novel pharmacological targets for cannabinoids. Curr Neuropharmacol. 2004;2:9\u201329."}, {"Citation": "Pertwee RG. Cannabinoid pharmacology: the first 66 years. Br J Pharmacol. 2006;147(S1):S163\u2013S171.", "ArticleIdList": ["PMC1760722", "16402100"]}, {"Citation": "Pertwee RG. Inverse agonism at cannabinoid receptors. Inverse agonism; Proceedings of the Esteve Foundation Symposium X, Girona, Spain, 2\u20135 October 2002; Amsterdam: Elsevier; 2003. pp. 75\u201386."}, {"Citation": "Pertwee RG. Pharmacological actions of cannabinoids. Cannabinoids. Handb Exp Pharmacol. 2005;(168):1\u201351.", "ArticleIdList": ["16596770"]}, {"Citation": "Pertwee RG. Pharmacology of cannabinoid CB 1 and CB 2 receptors. Pharmacol Ther. 1997;74:129\u2013180.", "ArticleIdList": ["9336020"]}, {"Citation": "Pertwee RG, Gibson TM, Stevenson LA, Ross RA, Banner WK, Saha B, et al. O\u20101057, a potent water\u2010soluble cannabinoid receptor agonist with antinociceptive properties. Br J Pharmacol. 2000;129:1577\u20131584.", "ArticleIdList": ["PMC1572002", "10780961"]}, {"Citation": "Pestonjamasp VK, Burstein SH. Anandamide synthesis is induced by arachidonate mobilizing agonists in cells of the immune system. Biochim Biophys Acta. 1998;1394:249\u2013260.", "ArticleIdList": ["9795237"]}, {"Citation": "Petri G. Cannabis sativa: in vitro production of cannabinoids. Med Aromatic Plants I. 1988;4:333\u2013349."}, {"Citation": "Price TJ, Patwardhan A, Akopian AN, Hargreaves KM, Flores CM. Modulation of trigeminal sensory neuron activity by the dual cannabinoid\u2013vanilloid agonists anandamide, N\u2010arachidonoyl\u2010dopamine and arachidonyl\u20102\u2010chloroethylamide. Br J Pharmacol. 2004;141:1118\u20131130.", "ArticleIdList": ["PMC1574881", "15006899"]}, {"Citation": "Pross S, Nakano Y, Smith J, Widen R, Rodriguez A, Newton C, et al. Suppressive effect of tetrahydrocannabinol on specific T cell subpopulations in the thymus. Thymus. 1992;19:97\u2013104.", "ArticleIdList": ["1313999"]}, {"Citation": "Raharjo TJ, Chang W-T, Verberne MC, Peltenburg-Looman AM, Linthorst HJ, Verpoorte R. Cloning and over-expression of a cDNA encoding a polyketide synthase from Cannabis sativa. Plant Physiol Biochem. 2004;42:291\u2013297.", "ArticleIdList": ["15120113"]}, {"Citation": "Reece AS. Chronic toxicology of cannabis. Clin Toxicol. 2009;47:517\u2013524.", "ArticleIdList": ["19586351"]}, {"Citation": "Rieder SA, Chauhan A, Singh U, Nagarkatti M, Nagarkatti P. Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression. Immunobiology. 2010;215:598\u2013605.", "ArticleIdList": ["PMC3005548", "19457575"]}, {"Citation": "Rischer H, Ore\u0161i\u010d M, Sepp\u00e4nen-Laakso T, Katajamaa M, Lammertyn F, Ardiles-Diaz W, et al. Gene-to-metabolite networks for terpenoid indole alkaloid biosynthesis in Catharanthus roseus cells. Proc Natl Acad Sci USA. 2006;103:5614\u20135619.", "ArticleIdList": ["PMC1459402", "16565214"]}, {"Citation": "Saito T, Namera A, Miura N, Ohta S, Miyazaki S, Osawa M, et al. A fatal case of MAM-2201 poisoning. Forensic Toxicol. 2013;31:333\u2013337."}, {"Citation": "Samson M-T, Small-Howard A, Shimoda LM, Koblan-Huberson M, Stokes AJ, Turner H. Differential roles of CB1 and CB2 cannabinoid receptors in mast cells. J Immunol. 2003;170:4953\u20134962.", "ArticleIdList": ["12734338"]}, {"Citation": "Santos R, Hallak J, Leite J, Zuardi A, Crippa J. Phytocannabinoids and epilepsy. J Clin Pharm Ther. 2015;40:135\u2013143.", "ArticleIdList": ["25475762"]}, {"Citation": "Schaefer N, Peters B, Bregel D, Kneisel S, Auw\u00e4rter V, Schmidt PH, et al. A fatal case involving several synthetic cannabinoids. Toxichem Krimtech. 2013;80:248\u2013251."}, {"Citation": "Schwarz H, Blanco FJ, Lotz M. Anadamide, an endogenous cannabinoid receptor agonist inhibits lymphocyte proliferation and induces apoptosis. J Neuroimmunol. 1994;55:107\u2013115.", "ArticleIdList": ["7962480"]}, {"Citation": "Sewell RA, Poling J, Sofuoglu M. The effect of cannabis compared with alcohol on driving. Am J Addict. 2009;18:185\u2013193.", "ArticleIdList": ["PMC2722956", "19340636"]}, {"Citation": "Shin J, Cho H, Hwang SW, Jung J, Shin CY, Lee SY, et al. Bradykinin-12-lipoxygenase-VR1 signaling pathway for inflammatory hyperalgesia. Proc Natl Acad Sci USA. 2002;99:10150\u201310155.", "ArticleIdList": ["PMC126639", "12097645"]}, {"Citation": "Shoyama Y, Hirano H, Makino H. Cannabis, Pt X: The isolation and structures of four new propyl cannabinoid acids, tetrahydrocannabivarinic acid, cannabidivarinic acid, cannabichromevarinic acid and cannabigerovarinic acid, from Thai cannabis, \u2018Meao Variant\u2019. Chem Pharm Bull. 1977;25:2306\u20132311."}, {"Citation": "Simiand J, Keane M, Keane P, Soubrie P. SR 141716, a CB1 cannabinoid receptor antagonist, selectively reduces sweet food intake in marmoset. Behav Pharmacol. 1998;9:179\u2013181.", "ArticleIdList": ["10065938"]}, {"Citation": "Sirikantaramas S, Morimoto S, Shoyama Y, Ishikawa Y, Wada Y, Shoyama Y, et al. The gene controlling marijuana psychoactivity molecular cloning and heterologous expression of \u03b41-tetrahydrocannabinolic acid synthase from cannabis Sativa L. J Biol Chem. 2004;279:39767\u201339774.", "ArticleIdList": ["15190053"]}, {"Citation": "Sirikantaramas S, Taura F, Morimoto S, Shoyama Y. Recent advances in Cannabis sativa research: biosynthetic studies and its potential in biotechnology. Curr Pharm Biotechnol. 2007;8:237\u2013243.", "ArticleIdList": ["17691992"]}, {"Citation": "Small-Howard AL, Shimoda LM, Turner H. Anti-inflammatory potential of CB1-mediated cAMP elevation in mast cells. Biochem J. 2005;388:465\u2013473.", "ArticleIdList": ["PMC1138953", "15669919"]}, {"Citation": "Tanaka H, Degawa M, Kawata E, Hayashi J, Shoyama Y. Identification of Cannabis pollens using an allergic patient's immunoglobulin E and purification and characterization of allergens in Cannabis pollens. Forensic Sci Int. 1998;97:139\u2013153.", "ArticleIdList": ["9871993"]}, {"Citation": "Tanaka H, Goto Y, Shoyama Y. Monoclonal antibody based enzyme immunoassay for marihuana (cannabinoid) compounds+ J Immunoassay Immunochem. 1996;17:321\u2013342.", "ArticleIdList": ["8957763"]}, {"Citation": "Tanasescu R, Constantinescu CS. Cannabinoids and the immune system: an overview. Immunobiology. 2010;215:588\u2013597.", "ArticleIdList": ["20153077"]}, {"Citation": "Thomas BF, Gilliam AF, Burch DF, Roche MJ, Seltzman HH. Comparative receptor binding analyses of cannabinoid agonists and antagonists. J Pharmacol Exp Ther. 1998;285:285\u2013292.", "ArticleIdList": ["9536023"]}, {"Citation": "Tognetto M, Amadesi S, Harrison S, Creminon C, Trevisani M, Carreras M, et al. Anandamide excites central terminals of dorsal root ganglion neurons via vanilloid receptor-1 activation. J Neurosci. 2001;21:1104\u20131109.", "ArticleIdList": ["PMC6762236", "11160380"]}, {"Citation": "Toguri J, Lehmann C, Laprairie R, Szczesniak AM, Zhou J, Denovan\u2010Wright EM, et al. Anti\u2010inflammatory effects of cannabinoid CB2 receptor activation in endotoxin\u2010induced uveitis. Br J Pharmacol. 2014;171:1448\u20131461.", "ArticleIdList": ["PMC3954484", "24308861"]}, {"Citation": "Tohge T, Nishiyama Y, Hirai MY, Yano M, Nakajima JI, Awazuhara M, et al. Functional genomics by integrated analysis of metabolome and transcriptome of Arabidopsis plants over\u2010expressing an MYB transcription factor. Plant J. 2005;42:218\u2013235.", "ArticleIdList": ["15807784"]}, {"Citation": "Trecki J, Gerona RR, Schwartz MD. Synthetic cannabinoid-related illnesses and deaths. N Engl J Med. 2015;373:103\u2013107.", "ArticleIdList": ["26154784"]}, {"Citation": "Ueda Y, Miyagawa N, Wakitani K. Involvement of cannabinoid CB 2 receptors in the IgE-mediated triphasic cutaneous reaction in mice. Life Sci. 2007;80:414\u2013419.", "ArticleIdList": ["17055000"]}, {"Citation": "Vanessa Ho WS, Hiley CR. Vasodilator actions of abnormal\u2010cannabidiol in rat isolated small mesenteric artery. Br J Pharmacol. 2003;138:1320\u20131332.", "ArticleIdList": ["PMC1573773", "12711633"]}, {"Citation": "Wang M, Richards AL, Friedman H, Djeu JY. Selective inhibition of natural killer but not natural cytotoxic activity in a cloned cell line by delta-9-tetrahydrocannabinol. J Leukoc Biol. 1991;50:192\u2013197.", "ArticleIdList": ["1649242"]}, {"Citation": "Wang T, Collet JP, Shapiro S, Ware MA. Adverse effects of medical cannabinoids: a systematic review. Can Med Assoc J. 2008;178:1669\u20131678.", "ArticleIdList": ["PMC2413308", "18559804"]}, {"Citation": "Watanabe K, Matsuda M, Tateoka Y, Kimura T, Matsunaga T, Tanaka H, et al. Cross-reactivity of various tetrahydrocannabinol metabolites with a monoclonal antibody against tetrahydrocannabinolic acid. J Health Sci. 2000;46:310\u2013313."}, {"Citation": "Watzl B, Scuderi P, Watson RR. Influence of marijuana components (THC and CBD) on human mononuclear cell cytokine secretion in vitro. Adv Exp Med Biol. 1991;288:63\u201370.", "ArticleIdList": ["1659139"]}, {"Citation": "Weiss L, Zeira M, Reich S, Har-Noy M, Mechoulam R, Slavin S, et al. Cannabidiol lowers incidence of diabetes in non-obese diabetic mice. Autoimmunity. 2006;39:143\u2013151.", "ArticleIdList": ["16698671"]}, {"Citation": "Yagen B, Mechoulam R. Stereospecific cyclizations and isomerizations of cannabichromene and related cannabinoids. Tetrahedron Lett. 1969;10:5353\u20135356.", "ArticleIdList": ["5370766"]}, {"Citation": "Yeakel JK, Logan BK. Blood synthetic cannabinoid concentrations in cases of suspected impaired driving. J Anal Toxicol. 2013;37:547\u2013551.", "ArticleIdList": ["23965292"]}, {"Citation": "Yuan M, Kiertscher SM, Cheng Q, Zoumalan R, Tashkin DP, Roth MD. \u0394 9-Tetrahydrocannabinol regulates Th1/Th2 cytokine balance in activated human T cells. J Neuroimmunol. 2002;133:124\u2013131.", "ArticleIdList": ["12446015"]}, {"Citation": "Zawilska JB, Wojcieszak J. Spice/K2 drugs\u2013more than innocent substitutes for marijuana. Int J Neuropsychopharmacol. 2014;17:509\u2013525.", "ArticleIdList": ["24169044"]}, {"Citation": "Zhu LX, Sharma S, Stolina M, Gardner B, Roth MD, Tashkin DP, et al. \u0394-9-Tetrahydrocannabinol inhibits antitumor immunity by a CB2 receptor-mediated, cytokine-dependent pathway. J Immunol. 2000;165:373\u2013380.", "ArticleIdList": ["10861074"]}, {"Citation": "Zhu W, Friedman H, Klein TW. \u03949-Tetrahydrocannabinol induces apoptosis in macrophages and lymphocytes: involvement of Bcl-2 and caspase-1. J Pharmacol Exp Ther. 1998;286:1103\u20131109.", "ArticleIdList": ["9694974"]}, {"Citation": "Ziegler J, Voigtl\u00e4nder S, Schmidt J, Kramell R, Miersch O, Ammer C, et al. Comparative transcript and alkaloid profiling in Papaver species identifies a short chain dehydrogenase/reductase involved in morphine biosynthesis. Plant J. 2006;48:177\u2013192.", "ArticleIdList": ["16968522"]}, {"Citation": "Zygmunt PM, Petersson J, Andersson DA, Chuang HH, S\u00f8rg\u00e5rd M, Di Marzo V, et al. Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature. 1999;400(6743):452\u2013457.", "ArticleIdList": ["10440374"]}]}], "History": [{"Year": "2017", "Month": "3", "Day": "7"}, {"Year": "2017", "Month": "4", "Day": "29"}, {"Year": "2017", "Month": "8", "Day": "23", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "8", "Day": "23", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "8", "Day": "23", "Hour": "6", "Minute": "1"}, {"Year": "2017", "Month": "5", "Day": "15"}], "PublicationStatus": "epublish", "ArticleIdList": ["28827985", "PMC5547394", "10.17179/excli2017-257", "2017-257"]}}]}